UBS AM’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-300,621
Closed -$2.66M 2628
2022
Q3
$2.66M Buy
300,621
+29,176
+11% +$367K ﹤0.01% 1454
2022
Q2
$3.43M Sell
271,445
-9,474
-3% -$121K ﹤0.01% 1361
2022
Q1
$5.31M Sell
280,919
-26,039
-8% -$663K ﹤0.01% 1329
2021
Q4
$10.8M Sell
306,958
-115,806
-27% -$3.76M ﹤0.01% 1102
2021
Q3
$15.5M Buy
422,764
+22,409
+6% +$881K 0.01% 937
2021
Q2
$15.7M Buy
400,355
+29,334
+8% +$847K 0.01% 959
2021
Q1
$10.5M Buy
371,021
+822
+0.2% +$26.2K ﹤0.01% 1074
2020
Q4
$11.9M Buy
370,199
+62,704
+20% +$1.93M 0.01% 998
2020
Q3
$9.93M Buy
307,495
+66,476
+28% +$2.07M 0.01% 946
2020
Q2
$6.65M Sell
241,019
-6,165
-2% -$134K ﹤0.01% 1026
2020
Q1
$4.41M Buy
247,184
+7,900
+3% +$191K ﹤0.01% 1084
2019
Q4
$6M Buy
239,284
+10,340
+5% +$226K ﹤0.01% 1118
2019
Q3
$4.08M Buy
228,944
+39,188
+21% +$816K ﹤0.01% 1286
2019
Q2
$4.17M Buy
189,756
+16,800
+10% +$479K ﹤0.01% 1258
2019
Q1
$5.29M Buy
172,956
+19,200
+12% +$479K ﹤0.01% 1131
2018
Q4
$3.55M Buy
+153,756
New +$4.78M ﹤0.01% 1202

Other funds holding HCM

UBS AM's HCM Position: Q4 2022 in Review

UBS AM sold out of HUTCHMED (HCM) in Q4 2022, closing a stake of 300,621 shares — an estimated $2.66M sold.

UBS AM first reported a position in HCM in Q4 2018 and held it in 16 quarters. The position peaked at $15.7M in Q2 2021. 84 funds tracked by Wall St. Rank hold HCM as of Q4 2022.

  • UBS AM reported no remaining HUTCHMED position as of Q4 2022 after selling out during the quarter.
  • UBS AM sold 300,621 HUTCHMED shares in Q4 2022, an estimated $2.66M.
  • UBS AM first reported a position in HUTCHMED in Q4 2018 and held it in 16 quarters.
  • UBS AM's HUTCHMED position peaked at $15.7M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held HUTCHMED as of Q4 2022.

Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.